The veterinary medical arm of Boehringer Ingelheim (Canada) Ltd., Animal Health Division prides itself on being a provider of solutions that reduce disease in Canadian livestock and improving the health and quality of life for companion animals.
With innovative biological and specialty pharmaceutical products, direct links to a renowned global research and development team, and industry-leading technical service veterinarians, Animal Health is focused on serving the needs of Canadian veterinarians and their animal patients.
In this highly competitive industry, companies that stay ahead of the curve and work in partnership with all intersecting partners, are the ones that remain in the foreground. Boehringer Ingelheim is one of those companies.
Boehringer Ingelheim (Canada) Ltd. works with advanced products, not only to reduce disease and encourage wellness in animals, but also to build the reputation and enhance the quality of care delivered by our veterinary customers, hence increasing their profitability.
As known leaders and innovators in this field, Boehringer Ingelheim (Canada) Ltd. is frequently consulted for assistance in identifying new diseases and formulating new therapies or new diagnostic techniques to control disease.
At Boehringer Ingelheim (BI), we like to challenge the status quo.
We are the only animal health manufacturer to launch four new, ground-breaking, patient friendly pet vaccines and three new small animal pharmaceuticals in four years!
At BI, we are constantly striving towards a better future and a better life for your pet. Click here to learn more about our product portfolio.
In November 2006, launched Ingelvac CircoFLEX®, an innovative ONE dose vaccine against porcine circovirus (PCV2), that causes immune deficiency. More than 130 million doses sold globally.
Introduced Ingelvac CircoFLEX-MycoFLEX® combo to protect pigs against both PCV2 and Mycoplasma hyopneumoniae with only ONE vaccine. Easy on the producer and the pig!
Our Enterisol Ileitis vaccine against Lawsonia is administered via water. This unique product is available as a frozen or nonfrozen form.
Our Swine portfolio includes 3 PRRS vaccines: PRRS MLV, PRRS ATP and ReproCyc PRRS-PLE to help you win the battle.
The foundation of a healthy and productive herd is a herd health program developed with your veterinarian to meet the specific needs of your herd and operation.
We believe there is a different way to enhance animal wellness beyond simply treating problems when they surface. Prevention is a common sense way to improve overall herd health that goes beyond vaccination protocols.
At Boehringer Ingelheim (Canada) Ltd., we have taken an approach to bovine health that is better for cattle, the consumer and your operation. We offer a broad portfolio with innovative solutions for the prevention and treatment of diseases in both beef and dairy cattle.
Calvenza® is an equine influenza and herpes virus combination vaccine that contains the most current equine influenza strain on the market.
Vetera™ is a line of equine vaccines with combinations that include West Nile virus, Eastern and Western Encephalomyelitis, Influenza, Herpes and Tetanus.
Ventipulmin® is the most trusted bronchodilator approved for use in horses in Canada, for the treatment of acute and chronic airway diseases.
Sputolysin®, a product used to soften and remove respiratory mucus, complements the use of Ventipulmin®.
Innovative, dedicated and market-oriented, Boehringer Ingelheim (Canada) Ltd., Animal Health Division, is the veterinarian's source for the most advanced and effective animal health solutions available.